BiOptic | AI for Cancer Drug Discovery

Our team

Dr. Artem Cherkasov

[ Chief Science Officer ]

Tier 1 Canada Research Chair in precision cancer drug discovery

UBC Professor of Medicine, VPC head of therapeutic development

Co-developed 8 drugs, 3 in clinical trials

Andrey Doronichev

[ Founder / CEO ]

Serial Tech Entrepreneur

Former Director of Product at Google

Vlad Vinogradov

[ Co-founder / CTO of Optic ]

AI research lead with 10 years of experience

Creator of Optic’s ultra-fast similarity search engine

Roman Doronin

[ Co-founder / CPO of Optic ]

AI lab operation leader

Former CEO of EORA.AI (80+ AI projects for Pepsico, Nestle, etc)

Dr. Alexander Tropsha

[ Advisor ]

Professor at UNC-Chapel Hill

Associate Dean for Pharmacoinformatics and Data Science at the UNC Eshelman School of Pharmacy

h-index: 84, Citations: 34,560

Dr. Martin Gleave

[ Advisor ]

Chairman of the Department of Urologic Sciences at UBC

Co-Founder and Director of the Vancouver Prostate Centre

Surgeon-scientist focused on resistance in cancer

Founded OncoGenex Pharmaceuticals and patented several anti-cancer drugs

h-Index: 122, Citations : >60,000

Dr. Olexandr Isayev

[ Advisor ]

Associate Professor, Chemistry at Carnegie Melon University

Computational Chemistry, Machine Learning, Deep Learning, Drug Discovery

h-index: 39, Citations: 10,510

Want to reach out directly? We’re always happy to talk!